Literature DB >> 24653594

A patient with Marfan's syndrome presented with severe rheumatic mitral stenosis and successfully treated with percutaneous transmitral balloon commissurotomy - Report of first case.

Chamrajnagar Mahadevappa Nagesh1, Soumya Patra1, Ajitpal Singh1, Srinivas C Badnur1, Babu Reddy1, Manjunath C Nanjappa1.   

Abstract

Marfan's syndrome (MFS) is an inherited autosomal dominant disorder of connective tissue with mutation on the fibrillin-1 gene encoding for fibrillin. This frequently involves the cardiovascular system with prevalence is 1:5000-10,000. The clinical major criteria involve the skeletal and ocular apparatus and the cardiovascular and central nervous system. In Marfan's syndrome mitral valve prolapse and aortic dilation are the main cardiovascular manifestations. According to the literature database the prevalence of aortic dilatation is 76%, 62% for mitral valve prolapse, 29% for mitral valve regurgitation and 26% for aortic regurgitation, in adult patients with Marfan's syndrome. We are reporting a case who presented with severe rheumatic mitral stenosis & later on examination found to be a case of Marfan's syndrome. This patient was successfully treated with percutaneous transmitral balloon commissurotomy. In medline search, so far there is no other case of Marfan's syndrome reported to have rheumatic mitral stenosis.

Entities:  

Keywords:  Marfan's syndrome; Mitral stenosis; Percutaneous transmitral commissurotomy; Rheumatic heart disease

Year:  2013        PMID: 24653594      PMCID: PMC3953700          DOI: 10.1016/j.jcdr.2013.04.002

Source DB:  PubMed          Journal:  J Cardiovasc Dis Res        ISSN: 0975-3583


  8 in total

Review 1.  Therapeutic management of patients with Marfan syndrome: focus on cardiovascular involvement.

Authors:  C A Nienaber; Y Von Kodolitsch
Journal:  Cardiol Rev       Date:  1999 Nov-Dec       Impact factor: 2.644

2.  Natural history of cardiovascular manifestations in Marfan syndrome.

Authors:  C D van Karnebeek; M S Naeff; B J Mulder; R C Hennekam; M Offringa
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

3.  Evidence for Marfan cardiomyopathy.

Authors:  Francisco Alpendurada; Joyce Wong; Anatoli Kiotsekoglou; Winston Banya; Anne Child; Sanjay K Prasad; Dudley J Pennell; Raad H Mohiaddin
Journal:  Eur J Heart Fail       Date:  2010-10       Impact factor: 15.534

Review 4.  Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.

Authors:  J De Backer
Journal:  Verh K Acad Geneeskd Belg       Date:  2009

5.  Cardiovascular manifestations in Marfan syndrome.

Authors:  S Figueiredo; E Martins; M R Lima; S Alvares
Journal:  Rev Port Cardiol       Date:  2001-12       Impact factor: 1.374

6.  [Prevalence of cardiovascular manifestations in Marfan syndrome].

Authors:  Maria Cristina Porciani; Monica Attanasio; Valentina Lepri; Ilaria Lapini; Gabriele Demarchi; Luigi Padeletti; Guglielmina Pepe; Rosanna Abbate; Gian Franco Gensini
Journal:  Ital Heart J Suppl       Date:  2004-08

7.  Biventricular and atrial diastolic function assessment using conventional echocardiography and tissue-Doppler imaging in adults with Marfan syndrome.

Authors:  Anatoli Kiotsekoglou; James C Moggridge; Bart H Bijnens; Venediktos Kapetanakis; Francisco Alpendurada; Michael J Mullen; Samir Saha; Dariush K Nassiri; John Camm; George R Sutherland; Anne H Child
Journal:  Eur J Echocardiogr       Date:  2009-09-29

8.  A critical analysis of minor cardiovascular criteria in the diagnostic evaluation of patients with Marfan syndrome.

Authors:  Julie De Backer; Bart Loeys; Dan Devos; Harry Dietz; Johan De Sutter; Anne De Paepe
Journal:  Genet Med       Date:  2006-07       Impact factor: 8.822

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.